Literature DB >> 3080048

Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites.

P Malasit, D A Warrell, P Chanthavanich, C Viravan, J Mongkolsapaya, B Singhthong, C Supich.   

Abstract

Victims of snake bites are often subjected to cutaneous or conjunctival hypersensitivity testing before being given antivenom. None of 12 early (anaphylactic) reactions was predicted by these tests in 25 Nigerian and Thai patients. The incidence and severity of early reactions was the same whether antivenom was given by intravenous injection over 10 minutes or diluted and given as an intravenous infusion over 30 minutes. Although antivenom activated complement in vitro, there was no evidence of complement activation or formation of immune complexes in patients bitten by snakes who were treated with antivenom, whether or not they developed early reactions. Higher doses of antivenom might induce the complement activation and formation of immune complexes (aggregates) that have been observed during the clinically more severe reactions associated with homologous immunoglobulin treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080048      PMCID: PMC1338972          DOI: 10.1136/bmj.292.6512.17

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

Review 1.  Diagnosis and management of envenomation by poisonous snakes.

Authors:  W A Wingert; J Wainschel
Journal:  South Med J       Date:  1975-08       Impact factor: 0.954

2.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Interaction of toxic venoms with the complement system.

Authors:  V Birdsey; J Lindorfer; H Gewurz
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

4.  The treatment of snakebite.

Authors:  P A Christensen
Journal:  S Afr Med J       Date:  1969-10-11

5.  Clinical use of antivenin prepared from goat serum.

Authors:  F E Russell; W F Timmerman; P E Meadows
Journal:  Toxicon       Date:  1970-05       Impact factor: 3.033

6.  Antivenom reactions and efficacy.

Authors:  H A Reid
Journal:  Lancet       Date:  1980-05-10       Impact factor: 79.321

7.  Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin.

Authors:  H Nielsen; H Sørensen; V Faber; S E Svehag
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  Snakebite and the use of antivenom in southern Africa.

Authors:  P A Christensen
Journal:  S Afr Med J       Date:  1981-06-20

9.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

10.  Adder bites in Britain.

Authors:  H A Reid
Journal:  Br Med J       Date:  1976-07-17
View more
  32 in total

Review 1.  Antivenom therapy in the Americas.

Authors:  K Heard; G F O'Malley; R C Dart
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 2.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Persistent coagulopathy in snake bite.

Authors:  Alka Khadwal; Bhavneet Bharti; Banani Poddar; Srikant Basu; Virender Singh Virdi; Veena Parmar
Journal:  Indian J Pediatr       Date:  2003-05       Impact factor: 1.967

Review 4.  Adverse reactions to snake antivenom, and their prevention and treatment.

Authors:  H Asita de Silva; Nicole M Ryan; H Janaka de Silva
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

Review 5.  Treatment of bites by adders and exotic venomous snakes.

Authors:  David A Warrell
Journal:  BMJ       Date:  2005-11-26

6.  Adverse drug reaction profile of anti-snake venom in a rural tertiary care teaching hospital.

Authors:  Rushikesh Prabhakar Deshpande; Vijay Motiram Motghare; Sudhir Laxman Padwal; Rakesh Ramkrishna Pore; Chetanraj Ghanshyam Bhamare; Vinod Shivaji Deshmukh; Harshal Nutan Pise
Journal:  J Young Pharm       Date:  2013-04-02

7.  A controlled clinical trial of a novel antivenom in patients envenomed by Bungarus multicinctus.

Authors:  Tran Hung Ha; Jonas Höjer; Xuan Kiem Trinh; Thi Du Nguyen
Journal:  J Med Toxicol       Date:  2010-12

8.  Anaphylaxis with Latrodectus antivenin resulting in cardiac arrest.

Authors:  Christine M Murphy; Jeannie J Hong; Michael C Beuhler
Journal:  J Med Toxicol       Date:  2011-12

Review 9.  Interventions for preventing reactions to snake antivenom.

Authors:  I Nuchpraryoon; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2000

10.  Process for production and purification of Lethal Toxin Neutralizing Factor (LTNF) from E. coli and its economic analysis.

Authors:  Vishwanath Hebbi; P Kathiresan; Devendra Kumar; Claire Komives; Anurag S Rathore
Journal:  J Chem Technol Biotechnol       Date:  2017-12-05       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.